Cipriani B - Search Results

1

Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates.

Aurisicchio L, Mennuni C, Giannetti P, Calvaruso F, Nuzzo M, Cipriani B, Palombo F, Monaci P, Ciliberto G, La Monica N. Aurisicchio L, et al. Among authors: cipriani b. Int J Cancer. 2007 Jun 1;120(11):2290-300. doi: 10.1002/ijc.22555. Int J Cancer. 2007. PMID: 17304509

2

Adenovirus vaccination against neu oncogene exerts long-term protection from tumorigenesis in BALB/neuT transgenic mice.

Gallo P, Dharmapuri S, Nuzzo M, Maldini D, Cipriani B, Forni G, Monaci P. Gallo P, et al. Among authors: cipriani b. Int J Cancer. 2007 Feb 1;120(3):574-84. doi: 10.1002/ijc.22274. Int J Cancer. 2007. PMID: 17096348

3

Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.

Mennuni C, Ugel S, Mori F, Cipriani B, Iezzi M, Pannellini T, Lazzaro D, Ciliberto G, La Monica N, Zanovello P, Bronte V, Scarselli E. Mennuni C, et al. Among authors: cipriani b. Cancer Res. 2008 Dec 1;68(23):9865-74. doi: 10.1158/0008-5472.CAN-08-1603. Cancer Res. 2008. PMID: 19047167

4

ErbB2 genetic cancer vaccine in nonhuman primates: relevance of single nucleotide polymorphisms.

Fattori E, Aurisicchio L, Zampaglione I, Arcuri M, Cappelletti M, Cipriani B, Mennuni C, Calvaruso F, Nuzzo M, Ciliberto G, Monaci P, La Monica N. Fattori E, et al. Among authors: cipriani b. Hum Gene Ther. 2009 Mar;20(3):253-65. doi: 10.1089/hum.2008.153. Hum Gene Ther. 2009. PMID: 19257854

5

Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacy.

Cipriani B, Fridman A, Bendtsen C, Dharmapuri S, Mennuni C, Pak I, Mesiti G, Forni G, Monaci P, Bagchi A, Ciliberto G, La Monica N, Scarselli E. Cipriani B, et al. Hum Gene Ther. 2008 Jul;19(7):670-80. doi: 10.1089/hum.2007.127. Hum Gene Ther. 2008. PMID: 18533895

6

A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine.

Conforti A, Cipriani B, Peruzzi D, Dharmapuri S, Kandimalla ER, Agrawal S, Mori F, Ciliberto G, La Monica N, Aurisicchio L. Conforti A, et al. Among authors: cipriani b. Vaccine. 2010 Apr 30;28(20):3522-30. doi: 10.1016/j.vaccine.2010.03.020. Epub 2010 Mar 21. Vaccine. 2010. PMID: 20332048

7

Adenovirus as vehicle for anticancer genetic immunotherapy.

Gallo P, Dharmapuri S, Cipriani B, Monaci P. Gallo P, et al. Among authors: cipriani b. Gene Ther. 2005 Oct;12 Suppl 1:S84-91. doi: 10.1038/sj.gt.3302619. Gene Ther. 2005. PMID: 16231059 Review.

8

Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes.

Ugel S, Scarselli E, Iezzi M, Mennuni C, Pannellini T, Calvaruso F, Cipriani B, De Palma R, Ricci-Vitiani L, Peranzoni E, Musiani P, Zanovello P, Bronte V. Ugel S, et al. Among authors: cipriani b. Blood. 2010 Feb 18;115(7):1374-84. doi: 10.1182/blood-2009-07-233270. Epub 2009 Nov 10. Blood. 2010. PMID: 19903903 Free article.

9

In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.

Ugel S, Zoso A, De Santo C, Li Y, Marigo I, Zanovello P, Scarselli E, Cipriani B, Oelke M, Schneck JP, Bronte V. Ugel S, et al. Among authors: cipriani b. Cancer Res. 2009 Dec 15;69(24):9376-84. doi: 10.1158/0008-5472.CAN-09-0400. Cancer Res. 2009. PMID: 19934317 Free PMC article.

10

Immunological markers of cancer vaccine efficacy and their clinical relevance.

Cipriani B. Cipriani B. Biomark Med. 2009 Jun;3(3):253-64. doi: 10.2217/bmm.09.18. Biomark Med. 2009. PMID: 20477477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters